Second Phase of ADVANTAGE AF study of FARAPULSE ™ Pulsed Field Ablation System Meets Primary Safety and Efficacy Endpoints
Trial achieves positive results in the treatment of persistent atrial [...]
Trial achieves positive results in the treatment of persistent atrial [...]
Legare Boyle, RN, of Greenville, South Carolina rewarded for compassionate [...]
Marianne Cracchiolo Mago, CEO of The Steele Foundation: “My father’s [...]
Overwater Ventures, GV, and Khosla Ventures invest in a rigorous [...]
The new RED 72 SILVER LABEL with SENDit® Technology has shown [...]
A new 2025 Global Trauma Devices Market Report reveals critical [...]
Four Sigmatic, the #1 functional coffee brand, announced the debut [...]
The trial evaluates R3 Vascular’s next-generation drug-eluting bioresorbable scaffold, MAGNITUDE®, [...]
Climate-controlled field hospitals have emerged as critical innovations in humanitarian [...]
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today [...]